Clinical trial
Novel Asthma Biomarkers to Predict the Response to Inhaled Corticosteroid
NCT01973751 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Asthma Biomarkers to Predict the Response to Inhaled Corticosteroid
- Lead sponsor
- Tongji Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2013
- Completion date
- July 31, 2016
- Enrollment
- 148 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.